Clinical Trials Directory

Trials / Sponsors / Paratek Pharmaceuticals Inc

Paratek Pharmaceuticals Inc

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bac
Bacterial Infections
Phase 12022-04-06
CompletedOral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (
Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease
Phase 22021-10-15
CompletedOmadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
Community-acquired Pneumonia, Bacterial Pneumonia
Phase 32021-02-25
CompletedStudy to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
Community-acquired Pneumonia
Phase 12019-11-28
CompletedIV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
Acute Pyelonephritis
Phase 22018-11-19
CompletedOral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
Uncomplicated Urinary Tract Infection, Cystitis
Phase 22018-01-04
CompletedOral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
Bacterial Infections, Skin Structures and Soft Tissue Infections
Phase 32016-08-01
CompletedOmadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
Bacterial Pneumonia, Community-Acquired Infections
Phase 32015-11-01
CompletedOmadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
Bacterial Infections, Skin Structures and Soft Tissue Infections
Phase 32015-06-01
WithdrawnPhase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection
Skin Structures and Soft Tissue Infections
Phase 32009-07-01
TerminatedStudy the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSS
Skin Diseases, Infectious
Phase 32009-04-04
CompletedStudy the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSS
Infectious Skin Disease, Bacterial Skin Disease
Phase 22007-07-18